Pricing Log in Create free account

Jaguar Animal Health, Inc. (JAGX) vs Matinas Biopharma Holdings, Inc. (MTNB)

Jaguar Animal Health, Inc. and Matinas Biopharma Holdings, Inc. are both Biotechnology companies. Matinas Biopharma Holdings, Inc. is the larger, with a market value of $1.1M against $950.0K — 1.2× the size. Matinas Biopharma Holdings, Inc. grew revenue faster over the last twelve months: 2,135.9% against 135.5%. Matinas Biopharma Holdings, Inc. has the higher net margin (0.00% vs −188.5%) and the higher return on invested capital (−419.3% vs −28,393.6%). Across the 19 metrics below, Matinas Biopharma Holdings, Inc. leads on 13 and Jaguar Animal Health, Inc. on 6.

Valuation

Metric JAGX MTNB Biotechnology median
P/E n/m n/m 10.60
P/S 0.00 0.12 9.40
P/B 0.00 0.30 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.14 0.04 0.66
EV/Sales (0.12) (0.06) 9.02
Earnings yield (1,425,993.60%) (1,403.30%) (32.88%)
Free cash flow yield (34,129.63%) (1,142.24%) (23.13%)

Profitability

Metric JAGX MTNB Biotechnology median
Gross margin 82.31% 0.00% 68.51%
Operating margin (93.10%) 0.00% 0.00%
Net margin (188.46%) 0.00% 0.00%
Free cash flow margin (24.03%) 0.00% 0.00%
Return on equity (1,125.38%) (154.28%) (51.96%)
Return on assets (127.14%) (98.53%) (46.06%)
Return on invested capital (28,393.64%) (419.27%) 0.00%

Growth

Metric JAGX MTNB Biotechnology median
Revenue growth (TTM) 135.52% 2,135.91% 6.76%
EPS growth (last fiscal year) 82.42% 59.84% 29.88%
Revenue growth, 5-year CAGR 4.17% 55.69% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JAGX MTNB Biotechnology median
Debt to equity 0.35 0.00 0.00
Current ratio 0.69 0.85 4.97
Net debt to EBITDA (0.17) 0.62 1.01

Dividend

Metric JAGX MTNB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric JAGX MTNB Biotechnology median
Market cap 950.00k 1.14m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack